언어 선택

CNR1

CNR1 분자 정보

영어 이름	Cannabinoid CB1 receptor	시판 약물 수	2
임상 약물 수	38	표적 별명	Cannabinoid Receptor 1 (Brain)，CNR1，Cannabinoid Receptor 1，CANN6，CB-R，CNR，CB1，Central Cannabinoid Receptor，CB1K5，CB1A，CB1R，Receptor， Cannabinoid， CB1
최고 연구 개발 단계	Approved

영어 이름	Cannabinoid CB1 receptor
표적 별명	Cannabinoid Receptor 1 (Brain)，CNR1，Cannabinoid Receptor 1，CANN6，CB-R，CNR，CB1，Central Cannabinoid Receptor，CB1K5，CB1A，CB1R，Receptor， Cannabinoid， CB1
시판 약물 수	2
임상 약물 수	38
최고 연구 개발 단계	Approved

CNR1 제품 목록

속성
Protein (3)
제품 라이브러리
온라인 (3)
종
Human (3)
태그
- (1)His Tag & Flag Tag (1)His Tag & Avi Tag & Flag Tag (1)
마커
Unconjugated (2)Biotin-labeled (1)

제품 번호	종	발현 시스템	제품 설명
CN1-H52P6	Human	HEK293	Human CNR1 Full Length Protein (VLP)
CN1-H55D3	Human	InsectCells	Human CNR1 Protein, Flag,His Tag (Detergent)
CN1-H85D3	Human	InsectCells	Biotinylated Human CNR1 Protein, Flag Tag&His,Avitag™ (Detergent)

총 수량3

CNR1분자 배경

This gene encodes one of two cannabinoid receptors. The cannabinoids, principally delta-9-tetrahydrocannabinol and synthetic analogs, are psychoactive ingredients of marijuana. The cannabinoid receptors are members of the guanine-nucleotide-binding protein (G-protein) coupled receptor family, which inhibit adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. The two receptors have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. Multiple transcript variants encoding two different protein isoforms have been described for this gene. [provided by RefSeq, May 2009]

CNR1분자 별명

CNR1,cannabinoid receptor 1,CANN6, CB-R, CB1, CB1A, CB1K5, CB1R, CNR

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
Dronabinol(AXIM Biotechnologies)		Phase 3 Clinical	Axim Biotechnologies Inc	Anorexia Nervosa; Cachexia; Child Nutrition Disorders; Nausea; Neoplasms; Nutrition Disorders; Sarcopenia; Vomiting	상세
Cannabidiol soft-gel (Avecho Biotechnology)	CBD-TPM	Phase 3 Clinical	Avecho Biotechnology Ltd	Sleep Initiation and Maintenance Disorders	상세
Cannabidiol Gel (Zynerba)	ZYN002; ZYN-002	Phase 3 Clinical	Zynerba Pharmaceuticals Inc	DiGeorge Syndrome; Fragile X Syndrome	상세
Adezunap	AP-707	Phase 3 Clinical	CannaXan GmbH	Accidental Injuries; Back Pain; Brachial Plexus Neuropathies; Brain Injuries, Traumatic; Chronic Pain; Diabetes Mellitus; Diabetic Neuropathies; Diabetic peripheral neuropathy; Low Back Pain; Multiple Sclerosis; Neuralgia; Pain; Pain, Postoperative; Paraplegia; Peripheral Nerve Injuries; Peripheral Nervous System Diseases; Phantom Limb; Somatoform Disorders; Stroke	상세
Dronabinol（Vertanical）	VER-01	Phase 3 Clinical	Vertanical GmbH	Low Back Pain	상세
cannabidiol (Cardiol Therapeutics)		Phase 3 Clinical	Cardiol Therapeutics Inc	Cardiovascular Diseases; Coronavirus Disease 2019 (COVID-19); Myocarditis; Pericarditis	상세
Selonabant	V-24343; ANEB-001; VER-24343	Phase 2 Clinical	Vernalis Plc	Obesity; Poisoning	상세
11C-MePPEP	11C-MePPEP	Phase 2 Clinical	Eli Lilly And Company	Obesity; Substance-Related Disorders	상세
AX-1602	AX-1602	Phase 2 Clinical	Axim Biotechnologies Inc	Dermatitis, Atopic; Psoriasis; Vitiligo	상세
Nimacimab	RYI-018; RYI-028; JNJ-2463	Phase 2 Clinical	Bird Rock Bio Inc	Diabetic Gastroparesis; Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity; Renal Insufficiency, Chronic	상세
ART-2713	NEO-1940; ART-2713; ART27.13; AZD-1940	Phase 2 Clinical	Astrazeneca Plc, Neomed Inc, Pfizer Inc	Anorexia; Cachexia; Low Back Pain; Pain; Weight Loss	상세
AEF-0217	AEF-0217	Phase 2 Clinical	Aelis Farma	Down Syndrome	상세
Monlunabant	S-MRI-1891; (-)-MRI-1891; NN9440–INV-202; INV-202; MRI-1891	Phase 2 Clinical	Inversago Pharma Inc	Diabetic Nephropathies; Metabolic Diseases; Metabolic Syndrome; Obesity	상세
Cannabidiol (Ananda Scientific)	A-1002-N5S; A1002N5S	Phase 2 Clinical	Ananda Scientific Inc	Chronic Pain; Opioid-Related Disorders; Stress Disorders, Post-Traumatic; Tobacco Smoking; Tobacco Use Disorder	상세
Cannabidiol (Biopharmaceutical Research Company)	BRC-001	Phase 2 Clinical	Biopharmaceutical Research Company	Breast Neoplasms; Carcinoma, Ductal, Breast	상세
C20T5	C20T5	Phase 2 Clinical	Murdoch Childrens Research Institute		상세
C12T12	C12T12	Phase 2 Clinical	Murdoch Childrens Research Institute		상세
Suvadronabinol	THC-VHS-NEC; SBI-100; NB-1111; Sb-100 OE; SBI-100 OE; THCVHS; THCVHS-N; THCVHS-NE; UM-5050	Phase 2 Clinical	University Of Mississippi	Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension	상세
IGC-AD1	IGC-AD1	Phase 2 Clinical	University Of South Florida	Alzheimer Disease; Dementia; Psychomotor Agitation	상세
Lixosicone	AEF-0117	Phase 2 Clinical	Aelis Farma, National Institute On Drug Abuse	Marijuana Abuse	상세
ZYN-001	ZYN-001	Phase 1 Clinical	Zynerba Pharmaceuticals	Fibromyalgia; Neuralgia	상세
Tetrahydrocannabivarin	GWP-42004; THCV; O-4394; DELTA9-THCV; GW-42004	Phase 1 Clinical	Gw Pharmaceuticals Plc	Diabetes Mellitus, Type 2; Dyslipidemias; Hypercholesterolemia; Hyperglycemia; Metabolic Syndrome; Obesity, Morbid	상세
Cannabidiol/hydroxychloroquine	IHL-675A; IHL-675	Phase 1 Clinical	Incannex Healthcare Ltd	Arthritis, Rheumatoid; Respiratory Distress Syndrome, Adult	상세
Zevaquenabant	MRI-1867; (S)-MRI-1867; INV-101	Phase 1 Clinical	National Institutes Of Health	Scleroderma, Systemic	상세
Cannabidiol (Artelo Biosciences)	ART-12.11; ART12.11; ART-1211	Phase 1 Clinical	Artelo Biosciences Inc	Anxiety; Depression; Depressive Disorder	상세
S1-221	S1-221	Phase 1 Clinical	Delphian Therapeutics Australia Pty Ltd		상세
Cannabidiol (Tiamat Australia)	MRX-1	Phase 1 Clinical	Tiamat Australia Pty Ltd		상세
Atorvastatin Calcium Hydrate/Cannabidiol		Phase 1 Clinical	Indication Bioscience LLC	Coronary Disease; Dyslipidemias	상세
TPT0301	TPT-0301; TPT0301	Phase 1 Clinical	Tetra Pharm Technologies ApS	Chronic Pain	상세
INV-347	NN9441; NN-9441; INV-347	Phase 1 Clinical	Inversago Pharma Inc	Obesity	상세
IPI 201（Isosceles Pharmaceuticals Inc ）	IPI-201	Phase 1 Clinical		Pain, Postoperative	상세
CRB-913	CRB-913	Phase 1 Clinical	Jenrin Discovery LLC	Obesity	상세
GFB-024		Phase 1 Clinical	Takeda Pharma	Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Endocrine System Diseases; Kidney Diseases	상세
DBPR-211		Phase 1 Clinical	National Health Research Institutes	Diabetes Mellitus, Type 2	상세
MP-10X	MP-10X	Clinical	Medipure Holdings	Pain	상세
MP-20X	MP-20X	Clinical	Medipure Holdings	Anxiety Disorders; Mood Disorders	상세
Cannabidiol (Receptor Life Sciences)		Clinical	Receptor Life Sciences Inc	Autism Spectrum Disorder	상세
Cannabidiol/Palmitoylethanolamide	SCI–210; THX-210	Clinical	Therapix Biosciences Ltd	Autism Spectrum Disorder; Diabetic Neuropathies	상세

시판 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	가장 빠른 브랜드 이름	가장 빠른 승인 국가	가장 빠른 적응증	가장 빠른 승인 회사	가장 빠른 승인 날짜	적응증	임상 시험
Cannabidiol/Dronabinol	delta-9-THC/CBD; MPL-001; MPL-005; PPP-011; BOL-DP-o-04; GW-1000-02; PPP-001; MGC-ODT; GW-1000; KL16-012; THC-5	Approved	Gw Pharmaceuticals	Sativex, Qixleef, QIXLEEFTM	Canada	Cancer Pain; Chronic Pain; Muscle Spasticity; Neuralgia; Multiple Sclerosis	null	2005-04-01	Acute Pain; Agitation; Agoraphobia; Anorexia; Anxiety Disorders; Arthritis, Psoriatic; Arthritis, Rheumatoid; Back Pain; Cancer Pain; Cerebral Palsy; Chronic Pain; Corticobasal degeneration; Dementia; Depression; Depressive Disorder, Major; Diabetic Neuropathies; Drug Resistant Epilepsy; Essential Tremor; Genital Diseases, Male; Healthy Aging; Hepatic Insufficiency; Hidradenitis Suppurativa; Huntington Disease; Kidney Diseases; Low Back Pain; Malnutrition; Marijuana Abuse; Marijuana Use; Migraine Disorders; Multiple Sclerosis; Muscle Spasticity; Neck Pain; Neoplasms; Neuralgia; Neuralgia, Postherpetic; Neuromyelitis Optica; Opioid-Related Disorders; Osteoarthritis, Knee; Pain; Panic Disorder; Peripheral Nervous System Diseases; Phobia, Social; Psoriasis; Reflex Sympathetic Dystrophy; Renal Insufficiency; Renal Insufficiency, Chronic; Sciatica; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Social Behavior; Spasm; Spinal Cord Injuries; Squamous Cell Carcinoma of Head and Neck; Stress Disorde	상세
Cannabidiol	CHI-902; APH-1501; GLA-015; BTX-1503; BTX-1801; GWP-42003-P; BOL-DP-o-05; GW-42003; BTX-1204; PTL-101; BTX-1702; PBX-1308; BRCX-014; LYT-310; GWP-42003	Approved	Gw Pharmaceuticals Plc	Epidyolex, Cannepil, Epidiolex	United States	Epilepsies, Myoclonic; Lennox Gastaut Syndrome	null	2018-06-25	Acne Vulgaris; Acute Pain; Alcohol Abstinence; Alcoholic Intoxication; Alcoholism; Anemia, Sickle Cell; Anorexia Nervosa; Anxiety; Anxiety Disorders; Appetitive Behavior; Arthralgia; Arthritis, Psoriatic; Arthritis, Rheumatoid; Autism Spectrum Disorder; Autistic Disorder; Azotemia; Behavior, Addictive; Bipolar Disorder; Blepharospasm; Brain Diseases; Brain Injuries, Traumatic; Breast Neoplasms; Bruxism; Burnout, Psychological; Cachexia; Carcinoma, Non-Small-Cell Lung; Carpal Tunnel Syndrome; Central Nervous System Diseases; Child Behavior Disorders; Chronic Pain; Chronic Periodontitis; Chronic Urticaria; Cicatrix; Cognition Disorders; Cognitive Dysfunction; Colitis, Ulcerative; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Corticobasal degeneration; Craving; Crohn Disease; Cystitis, Interstitial; Dentin Sensitivity; Depression; Dermatitis, Atopic; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Driving Under the Influence; Drug Resistant Epilepsy; Dyslipidemias; Dysmenorrhea; Dyspepsia; Eczema;	상세